The AI, Data & Analysis program covers how AI and data science are changing precision drug development and diagnostics, and where human judgment remains critical. It is for data science and AI leads, bioinformaticians, and platform and infrastructure providers.

AI & Machine Learning for Data-Driven Precision Medicine
How AI, machine learning and advanced analytics turn complex biological and clinical data into insights that improve biomarker discovery, patient stratification, treatment selection and clinical outcomes.

AI in Multi-Omics: Hype, Reality, and What Comes Next

Every program at Precision Medicine East now generates more data than any one team can interpret alone, from multi-omic and spatial datasets to pathology images and patient records. AI, Data & Analysis is where the people who build the models meet the people who need them.

Advances in AI, machine learning and multimodal foundation models are helping researchers integrate complex datasets and uncover new biological insights. The question is how to ensure these approaches deliver reliable, reproducible results while addressing challenges around data quality, bias, interpretability and privacy.

At Precision Medicine East, the program runs alongside Biomarkers & CDx; Computational Pathology, AI & Precision Diagnostics; and Multi-Omics Development & Applications, so data scientists, bioinformaticians and drug developers can work through those questions together.